At Roche, it is not just about treating patients - it is about traveling this uphill road with them and their families. Improving access to effective, quality healthcare requires a combination of products, services, systems and resources. In an attempt to overcome this challenge, Roche Pharma India works dedicatedly to reduce such barriers, enable access and meet patients’ unmet needs. Know more about The Blue Tree Program with this film.

People living with cancer, hemophilia and rare diseases have a variety of support needs and we recognize them. Patient assistance matters as much as clinical efficacy and healthcare delivery. Impactful patient assistance is linked to improved patient outcomes and lower costs, and contributes significantly to creating healthcare access in the country. Towards this, The Blue Tree Program provides a bouquet of 11 services to help patients and their caregivers navigate the complex treatment journey.

Roche Pharma India’s The Blue Tree Program offers support to cancer, hemophilia and rare disease patients during their entire treatment journey — from diagnosis to completion of therapy. It is a comprehensive patient support initiative that is designed to take care of the multiple hurdles that a patient has to go through during the course of receiving treatment. Here’s a snapshot of the services offered under The Blue Tree Program:

Since its launch, The Blue Tree Program has:

  • Benefited 11000+ patients across India

  • Partnered with 750+ doctors

  • Partnered with 300+ cancer care centers pan India

  • Conducted 1800+ diagnostic tests

  • The Blue Tree Program was showcased as an effective and unique patient support programme at the United General Assembly (UNGA) Week – as part of the 72nd session of the UNGA in September 2017. 

To avail support from The Blue Tree program, patients and caregivers can reach out to their healthcare providers or connect with The Blue Tree administrator on toll-free numberWhatsAppor email us at: 

The Blue Tree app is available for download on both Google Play Store and App Store.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us atOR please call the Roche India Safety Unit onor E-mail us at